Skip to main content
. 2021 Sep 12;11(9):909. doi: 10.3390/jpm11090909

Table 3.

Follow-up.

Histology Adjuvant Therapy (%) Median Overall Survival (Months)
With Adj. Therapy Without Adj. Therapy p *
Whole group 72.0 11 2 0.0002
HGG 72.1 7.5 2 <0.0001
PCNSL 76.5 19 1 0.0008
Other 66.7 not reached not reached 0.3765

Adj, adjuvant; HGG, high-grade glioma; PCNSL, primary central nervous system lymphoma. * Log-rank test.